Home

James Dyson likely violent glaxosmithkline market cap At dawn out of service Bread

UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction -  Bloomberg
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg

GSK plc Share Price (GSK) ORD GBP0.3125 | GSK
GSK plc Share Price (GSK) ORD GBP0.3125 | GSK

GSK falls victim to 'hard to please' pharma market | LSE:GSK, NYSE:GSK
GSK falls victim to 'hard to please' pharma market | LSE:GSK, NYSE:GSK

Elliott Publishes Letter on GlaxoSmithKline
Elliott Publishes Letter on GlaxoSmithKline

GlaxoSmithKline PLC Stock Appears To Be Modestly Undervalued
GlaxoSmithKline PLC Stock Appears To Be Modestly Undervalued

The pharma industry key list - Pharma Technology Focus | Issue 103 |  February 2021
The pharma industry key list - Pharma Technology Focus | Issue 103 | February 2021

GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies

Stock Spotlight: Haleon spinout boosts GSK but firm remains dependant on  pipeline
Stock Spotlight: Haleon spinout boosts GSK but firm remains dependant on pipeline

GlaxoSmithKline to Acquire Tesaro for $4.16 Billion - WSJ
GlaxoSmithKline to Acquire Tesaro for $4.16 Billion - WSJ

GSK Stock: Haleon Demerger Retrospective (NYSE:GSK) | Seeking Alpha
GSK Stock: Haleon Demerger Retrospective (NYSE:GSK) | Seeking Alpha

GSK spinoff starts trading at LSE - what you need to know
GSK spinoff starts trading at LSE - what you need to know

Elliott Publishes Letter on GlaxoSmithKline
Elliott Publishes Letter on GlaxoSmithKline

Consumer goods arm of GSK hits stock market | This is Money
Consumer goods arm of GSK hits stock market | This is Money

Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?
Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?

Top-10 Biggest UK-based Companies 2023 | Hantec Markets
Top-10 Biggest UK-based Companies 2023 | Hantec Markets

Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide
Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide

4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio
4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio

Glaxo (GSK) to Report Q4 Earnings: What's in the Cards?
Glaxo (GSK) to Report Q4 Earnings: What's in the Cards?

GSK Stock: Vaccine Sales Drive Q2 Beat | Investor's Business Daily
GSK Stock: Vaccine Sales Drive Q2 Beat | Investor's Business Daily

GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap

Glaxosmithkline plc - ADR Shares Approach 52-Week High - Market Mover |  Nasdaq
Glaxosmithkline plc - ADR Shares Approach 52-Week High - Market Mover | Nasdaq

GSK consumer spin-off will create a major player in a sector ripe for  consolidation | Comment and Opinion | The Grocer
GSK consumer spin-off will create a major player in a sector ripe for consolidation | Comment and Opinion | The Grocer

Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016? | The  Motley Fool
Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016? | The Motley Fool

Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales | Nasdaq
Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales | Nasdaq

Unilever Needs $10 Billion Bump to Win Glaxo Unit, Analysts Say - BNN  Bloomberg
Unilever Needs $10 Billion Bump to Win Glaxo Unit, Analysts Say - BNN Bloomberg

GSK (GSK) Stock Price, News & Info | The Motley Fool
GSK (GSK) Stock Price, News & Info | The Motley Fool

LIC-backed GSK Pharma declares ₹32 per share dividend, net profit down 89%  YoY in Q4 | Mint
LIC-backed GSK Pharma declares ₹32 per share dividend, net profit down 89% YoY in Q4 | Mint